Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Gift Nifty Signals Strong Start for Indian Equities as Global Sentiment Improves Over Weekend Burberry Shares Climb as Report Suggests Moncler May Pursue Acquisition Bid Mercury Reaches 52 Billion Valuation in Latest Funding Round Marking 49 Increase Over 14 Months Tech Giants Pledge Up to 500 Billion for AI Infrastructure in US SP 500 Inches Higher as Consumer Stocks Rally Energy Drags Hinge Health Q1 2026 Earnings EPS Surpasses Estimates by 163 DHCNI Q1 2026 Earnings Net Loss Misses Estimates Amid Challenging Environment YDKG Q4 2012 Earnings EPS Misses Estimates Amidst Uncertain Operating Environment Alzamend Neuro Inc ALZN Q1 2026 Earnings NarrowerthanExpected Loss as EarlyStage Biotech Continues RD Focus Indaptus Therapeutics Q4 2025 Earnings EPS Miss Amid Continued RD Investment EW Scripps SSP Slips 2 as Shares Test Key Support at 325 Cellectar Biosciences Edges Higher Finding Support Near 304 Inspira Technologies Oxy BHN Ltd Warrant IINNW Stock Holds Steady at 014 Support and Resistance Levels in Focus LaFayette Acquisition Corp Unit LAFAU Holds Steady at 1006 Stability in a SPAC Market Bond Bull Market May Pause but Remains Intact Expert Suggests Tancoo Signals Deeper Collaboration with Banking Sector Potentially Reshaping Financial Services Landscape Yardeni Warns Fed May Need July Rate Hike to Appease Bond Vigilantes Even with Warsh at Helm Inherited House Sale Advice CPA Recommends Selling Within a Year for Tax Benefits CRDF Q1 2026 Earnings EPS Misses Estimates Stock Rises on Pipeline Progress Kartoon Studios Inc TOON Q3 2018 Earnings WiderThanExpected Loss Amid Stock Rally BRC Group Holdings RILYZ Q1 2024 Earnings Bondholder Impact Amid No Revenue Visibility and Negative EPS Solidion Technology Q4 2025 Earnings Continued Losses Amidst No Revenue Amdocs DOX Q1 2026 Earnings Slim EPS Miss Masks Steady Operational Performance Surrozen Inc SRZN Q1 2026 Earnings Significant EPS Miss Reflects Ongoing ClinicalStage Spending No Revenue Reported